Pharmaceutical costs

The pharmaceutical industry has long been one of the most profitable global industries, but its critics say it is too profit-oriented, pricing its drugs out of reach of the world's poor, inventing illnesses, not doing enough research and relaunching largely unchanged medicines at higher prices.

by IESE Insight
Last Updated: 23 Jul 2013

The industry takes advantage of the priority given by many governments to intellectual property rights over access to health rights, it is claimed.

Illustrating its generally bad reputation, a study of industry references in US newspapers found the number of unfavourable mentions more than double favourable ones.

However, the big companies claim their prices reflect product development and costs: bringing a drug to market can cost EUR350 million-EUR800 million and take up to 15 years. The author calls for a more constructive dialogue aimed at bringing agreement on a regulatory framework.

Do drug companies deserve their bad reputation?
Domenec Mele,
IESE Insight, June 2006

Review by Steve Lodge

Find this article useful?

Get more great articles like this in your inbox every lunchtime

Could coronavirus lead to gender equality?

Opinion: Enforced home-working and home-schooling could change the lives of working women, and the business...

Mike Ashley: Does it matter if the public hates you right now?

The Sports Direct founder’s response to the COVID-19 pandemic has drawn criticism, but in the...

4 films to keep you sane during the coronavirus lockdown

Cirrus CEO Simon Hayward shares some choices to put things in perspective.

Pandemic ends public love affair with Richard Branson et al

Opinion: The larger-than-life corporate mavericks who rose to prominence in the 80s and 90s suddenly...

The Squiggly Career: How to be a chief strengths spotter

When leading remotely, it's more important than ever to make sure your people spend their...

"Blind CVs don't improve your access to talent"

Opinion: If you want to hire socially mobile go-getters, you need to know the context...